where do you want to take your company now you can’t find any drug that’s going to be more successful than one you have is this you’re just going to keep promoting this drug is that your biggest thing or there’s no other drug you can I can imagine that would be anything comparable to this well we can imagine that and so we’re trying to uh first of all within the Obesity metabolic Health space I think there’s two things I’m very excited about one is we have tpde mararo zound on the market we have 11 other pipeline projects aimed at the same problem but in different ways so we have a triple acting uh medicine that’s in phase three for those that have even higher body weight or more severe health problems we have the oral project with nine others beyond that uh we think this this is going to be a very large segment with many different types of medicines for different conditions and different situations people might find themselves in we’re going to exploit that fully the second thing is we’ve talked a lot about like cardiovascular health diabetes these conditions that ones think about with being overweight but these medicines uh we think and we aim to prove can be useful for other things we don’t think about connected to weight uh these are often called anti-ed donics so they’re reducing that desire cycle so next year you’ll see Lily start large studies and alcohol abuse and nicotine use even in drug abuse um we’ll also begin studies in anti-inflammatory conditions because you don’t think of that with weight but actually there is a quite a strong signal in anti-inflammatory